Guardian Pharmacy Services Inc. has announced the pricing of its underwritten public offering of 7,500,000 shares of Class A common stock at $21.00 per share. Of these, 6,059,553 shares are being sold by certain stockholders, while 1,440,447 shares are part of a non-dilutive "synthetic secondary" transaction, which involves Guardian using the proceeds to repurchase the same number of shares. This approach ensures that the total number of outstanding shares remains unchanged. The offering, led by Raymond James with participation from Stephens Inc. and Truist Securities, is expected to close on May 27, 2025, pending customary conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.